Elevance Health (ELV) Stock
Large US health insurer with Medicare and Medicaid plans. Here's the price, business snapshot, and what's worth knowing about Elevance Health in October 2026.
Elevance Health, Inc (ticker: ELV) is a large-cap US health-insurance conglomerate offering managed-care plans, Medicare and Medicaid services, and a growing set of digital and value-based care solutions. With a market capitalisation of about $77.73B, the company generates revenue from premiums, care-management services and partnerships with providers. Key drivers include membership growth—especially in Medicare Advantage and Medicaid—cost-management efforts and investments in data and digital tools. Investors should note exposure to medical-cost trends, regulatory change and reimbursement pressures, which can affect margins and earnings volatility. The business has scale and diversification across commercial and government programmes, but returns are not guaranteed and share prices can fall as well as rise. This summary is for general educational purposes only and is not personalised investment advice; investors should consider their own risk tolerance, diversification needs and consult a financial adviser where appropriate.
Why It’s Moving
Elevance Health Unveils 2027 Medicare Advantage Plans Focused on Stability and Personalized Support
- New 2027 Medicare Advantage plans emphasize meaningful choice and simplified benefit experiences to help members navigate healthcare more confidently.
- The offerings include personalized support tailored to individual health needs, reflecting a shift toward coordinated care models.
- Recent sector analysis indicates Elevance Health is being compared against medical peers like American Well Corporation to assess relative performance trends.
Elevance Health Unveils 2027 Medicare Advantage Plans Focused on Stability and Personalized Support
- New 2027 Medicare Advantage plans emphasize meaningful choice and simplified benefit experiences to help members navigate healthcare more confidently.
- The offerings include personalized support tailored to individual health needs, reflecting a shift toward coordinated care models.
- Recent sector analysis indicates Elevance Health is being compared against medical peers like American Well Corporation to assess relative performance trends.
Sixth Month Growth Performance
When is the next earnings date for ELEVANCE HEALTH INC (ELV)?
No confirmed upcoming earnings date has been announced for ELV as of the current reporting cycle. Based on the historical pattern of reports occurring approximately three months after the previous quarter's close, the next release is expected in late October 2026. This report will cover the third quarter of fiscal year 2026 results. Investors should monitor official company communications for the precise scheduling confirmation.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Elevance Health's stock with a target price of $484.27, indicating growth potential.
Financial Health
Elevance Health is performing well with strong revenue and cash flow, indicating solid financial stability.
Dividend
Elevance Health's dividend yield of 1.78% is reasonable but not high. If you invested $1000 you would be paid $17.86 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Membership Growth Drivers
Medicare Advantage and Medicaid enrolment trends can support revenue expansion, though membership quality and medical costs influence outcomes.
US Market Exposure
Elevance is focused on the US health ecosystem and benefits from demographic ageing, but it remains sensitive to domestic policy and regulation.
Digital Innovation Push
Investments in data and care-management tech aim to reduce costs and improve outcomes, though execution and competition present ongoing risks.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
